Kyprolis

Active substance

carfilzomib

Holder

Amgen N.V.

Status

Closed

Indication

in combination with dexamethasone (Kd) for the treatment of adult patients with relapsed multiple myeloma who did receive 3 or more prior therapies

Public documents

Approbation

Information for the patient

Informed consent

Last update

31/07/2017

Last updated on 13/02/2024